Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking with Cabinet colleagues to help tackle male suicide.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Suicide Prevention Strategy for England, published on 11 September 2023, is a cross-Government strategy with over 100 actions that we believe will reduce the suicide rate within five years, with initial reductions observed within two and a half years. We have identified middle-aged men as a priority group within the strategy, and many of the actions will support suicide prevention in men by addressing the common risk factors for this group, such as a history of drug or alcohol misuse, family or relationships problems, and social isolation and loneliness. We have worked across departments to develop this strategy and will continue to do so, in order to deliver the actions within it.
In addition, on 23 August 2023 we launched a £10 million Suicide Prevention Grant Fund to support voluntary community and social enterprise organisations in England in meeting the demand for their services to support people experiencing suicidal thoughts, or approaching a mental health crisis. Applications were encouraged from charities to support middle-aged men and other groups of concern. The fund will run to March 2025, and we expect to start making this funding available to successful applicants very soon.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of trends in the number of incidences of sepsis in the last five years.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
The Department and NHS England do not hold information centrally on the incidences of sepsis, and have made no assessment of the trends. There is a lack of reliable estimates of the incidence and prevalence of sepsis due to a lack of consistency in the definitions used to describe sepsis, and differences in coding between professionals and organisations. Despite this, the focus on sepsis in recent years means there is now much better awareness and improved clinical recognition of sepsis symptoms.
The Office for National Statistics (ONS) does publish data on the number of death registrations where sepsis is mentioned anywhere on the death certificate in England and Wales between 2001 and 2022, as the data for 2023 has yet to be published. The following table shows the number of deaths registered where sepsis was mentioned anywhere on the death certificate in England and Wales in each of the last five years:
Year | Number of Deaths |
2018 | 23,185 |
2019 | 21,458 |
2020 | 19,324 |
2021 | 21,947 |
2022 | 25,542 |
The Department works with NHS England and the UK Health Security Agency to monitor sepsis death data. It is difficult to attribute the increase in the number of deaths registered where sepsis was mentioned anywhere on the death certificate from 2020 to 2022 to a single cause, as the incidences of infection and reasons for acute deterioration are complex and multifactorial. It is also possible that the increase reflects a greater awareness of sepsis and improved coding and recording of deaths due to sepsis.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps she is taking with Cabinet colleagues to help tackle (a) health inequalities and (b) social deprivation for people with (i) asthma and (ii) chronic obstructive pulmonary disease.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Government is undertaking several actions related to the causes of asthma and chronic obstructive pulmonary disease, and to tackle health inequalities and social deprivation faced by people with those conditions.
Firstly, the Government is undertaking a comprehensive review of how we communicate air quality information to ensure members of the public, and vulnerable groups in particular, have the information they need to protect themselves and understand their impact on air quality. This review is being undertaken by the Air Quality Information Systems steering group, with the group’s recommendations being published in summer of 2024.
Furthermore, the Government is committed to reducing air pollution from all forms of transport, including PM2.5, the most harmful pollutant to human health. The Environmental Improvement Plan sets out transport measures that will help reduce emissions of air pollutants as we approach a decarbonised transport system. Our transport decarbonisation plan will deliver improved air quality from reduced tailpipe emissions as we move towards a fully electrified vehicle fleet. Alongside this, we are investing in cutting-edge research to understand how to better measure and control brake and tyre emissions, including from zero tailpipe emission vehicles.
The Government also has a wide range of initiatives to support disabled people and people with health conditions to start, stay and succeed in work. These include work to further join up employment and health systems, including rolling out Employment Advice in NHS Talking Therapies, expanding the Individual Placement and Support in Primary Care initiative, and reforming Occupational Health provision.
Finally, the NHS England’s Core20Plus5 approach has been developed to support integrated care systems to reduce inequalities. The approach focuses on improving cardiovascular disease, cancer, respiratory, maternity and mental health outcomes in the poorest 20% of the population, along with ethnic minorities and inclusion health groups.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of trends in the level of people diagnosed with Alzheimer's in the last 10 years.
Answered by Helen Whately - Minister of State (Department of Health and Social Care)
Whilst no formal assessment has been made, we know that the number of people with dementia has increased. The latest dementia diagnosis rate reported by NHS England for the end of January 2024 was 64.4%.
A table showing the number of people with a primary diagnosis of Alzheimer’s each year from 2016 to 2023, as data is not available before 2016, broken down by the type and stage of the diagnosis is attached.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people aged under 18 have been prescribed medicinal cannabis as of 19 February 2024.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Department does not hold details relating to the age of people prescribed medicinal cannabis.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make an assessment with Cabinet colleagues of the potential merits of providing additional funding to the devolved Administrations to help support young people with (a) bulimia, (b) anorexia and (c) other eating disorders.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
There are currently no plans for such an assessment. As health is a predominantly devolved matter, and funding through the Barnett formula is not ringfenced for specific uses, it is for the devolved administrations to determine how much of their funding they allocate to specific healthcare services, including eating disorder services, in their nations.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to train specialist staff in the timely (a) diagnosis and (b) treatment of cancer.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The NHS Long Term Workforce Plan (LTWP) published by NHS England on 30 June 2023 sets out an aim to double the number of medical school places in England to 15,000 places a year by 2031/32, and to work towards this expansion by increasing places by a third, to 10,000 a year, by 2028/29.
The LTWP commits to an adequate growth in foundation placement capacity, as those taking up these new places begin to graduate, and a commensurate increase in specialty training places that meets the demands of the National Health Service in the future. This will substantially increase the potential pipeline for the cancer workforce. The Department is working closely with NHS England to make sure we have the right workforce with the right skills up and down the country.
There are more doctors working in clinical oncology and more radiology doctors. As of October 2023, there are almost 1,700 full time equivalent (FTE) doctors working on clinical oncology in NHS trusts and other core organisations in England. This is 5.2% more than last year, and 62.4% more than in 2010. Additionally, there are over 5,600 FTE doctors working in the speciality of clinical radiology in NHS trusts and other core organisations in England. This is over 300 5.7% more than last year, and 66.8% more than in 2010.
In 2023/24, NHS England is investing an additional £50 million to expand cancer and diagnostics specialists. On 10 January 2023, Health Education England announced that nearly 900 additional medical specialty training posts have been created for this year, including more than 500 in the key areas of mental health and cancer treatment.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to replace aging equipment in the NHS.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Individual National Health Service organisations are responsible for maintaining and replacing their existing assets. One source of funding for aging equipment is operational capital, which is issued to integrated care boards to prioritise the capital needs of the NHS, including renewal and replacement of plant, IT, and equipment. In order to facilitate the ongoing requirement for equipment, the Department has provided £4.2 billion in operational capital in 2023/24, amounting to over £12 billion over the spending review period of 2022/23 to 2024/25.
In addition to operational capital is the £2.3 billion which has been provided over the spending review period to transform diagnostic services, including replacing old equipment, and deliver 160 community diagnostic centres. One aim of this funding is to clear the current backlog of equipment over 10 years old by the end of the spending review period.
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what data her Department holds on the number of cases of (a) vascular and (b) venous disease.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Cardiovascular disease affects approximately seven million people in the United Kingdom, and is a significant cause of disability and death. Further information is available at the following link:
https://www.england.nhs.uk/ourwork/clinical-policy/cvd/
Asked by: Jim Shannon (Democratic Unionist Party - Strangford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if he will make an assessment of developing a cross-departmental strategy including the (a) Department for Science, Innovation and Technology and (b) NHS to (i) support and (ii) promote expertise in cell and gene therapy innovation.
Answered by Andrea Leadsom - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department recognises that advanced cell and gene therapies will be an important part of the future of healthcare and the life sciences industry. The Department has been considering the recommendations of the National Cell and Gene Therapy Vision for the UK, a report published by the Cell and Gene Therapy Catapult in March 2022, and the UK Strategic Stem Cell Forum’s latest report, A 10 Year Vision for Stem Cell Transplantation and Advanced Cellular Therapies, published in July 2022. As part of this we have been conducting stakeholder engagement across the cell and gene therapy ecosystem to further understand the challenges raised and whether there is a role for the Department in coordinating activity in this area. We will continue to work with our public sector partners to ensure a whole system approach to advanced therapies, building on existing strengths to ensure a joined-up research, regulatory, and health ecosystem.